91 related articles for article (PubMed ID: 8904627)
1. Lack of pharmacokinetic interaction between butorphanol nasal spray and cimetidine.
Shyu WC; Barbhaiya RH
Br J Clin Pharmacol; 1996 Oct; 42(4):513-7. PubMed ID: 8904627
[TBL] [Abstract][Full Text] [Related]
2. Lack of pharmacokinetic interaction between butorphanol tartrate nasal spray and sumatriptan succinate.
Srinivas NR; Shyu WC; Upmalis D; Lee JS; Barbhaiya RH
J Clin Pharmacol; 1995 Apr; 35(4):432-7. PubMed ID: 7650235
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of butorphanol and its metabolites at steady state following nasal administration in humans.
Vachharajani NN; Shyu WC; Greene DS; Barbhaiya RH
Biopharm Drug Dispos; 1997 Apr; 18(3):191-202. PubMed ID: 9113342
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic interaction between butorphanol nasal spray and oral metoclopramide in healthy women.
Vachharajani NN; Shyu WC; Barbhaiya RH
J Clin Pharmacol; 1997 Oct; 37(10):979-85. PubMed ID: 9505990
[TBL] [Abstract][Full Text] [Related]
5. Lack of interaction between nefazodone and cimetidine: a steady state pharmacokinetic study in humans.
Barbhaiya RH; Shukla UA; Greene DS
Br J Clin Pharmacol; 1995 Aug; 40(2):161-5. PubMed ID: 8562300
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of butorphanol nasal spray in patients with renal impairment.
Shyu WC; Morgenthien EA; Barbhaiya RH
Br J Clin Pharmacol; 1996 May; 41(5):397-402. PubMed ID: 8735680
[TBL] [Abstract][Full Text] [Related]
7. A pharmacokinetic interaction study between butorphanol and sumatriptan nasal sprays in healthy subjects: importance of the timing of butorphanol administration.
Vachharajani NN; Shyu WC; Nichola PS; Boulton DW
Cephalalgia; 2002 May; 22(4):282-7. PubMed ID: 12100090
[TBL] [Abstract][Full Text] [Related]
8. The absolute bioavailability and pharmacokinetics of butorphanol nasal spray in patients with hepatic impairment.
Vachharajani NN; Shyu WC; Garnett WR; Morgenthien EA; Barbhaiya RH
Clin Pharmacol Ther; 1996 Sep; 60(3):283-94. PubMed ID: 8841151
[TBL] [Abstract][Full Text] [Related]
9. Renal interaction between itraconazole and cimetidine.
Karyekar CS; Eddington ND; Briglia A; Gubbins PO; Dowling TC
J Clin Pharmacol; 2004 Aug; 44(8):919-27. PubMed ID: 15286096
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of butorphanol tartrate administered from single-dose intranasal sprayer.
Davis GA; Rudy AC; Archer SM; Wermeling DP
Am J Health Syst Pharm; 2004 Feb; 61(3):261-6. PubMed ID: 14986556
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, bioequivalence, and spray weight reproducibility of intranasal butorphanol after administration with 2 different nasal spray pumps.
Wermeling DP; Miller JL; Archer SM; Rayens MK; Rudy AC
J Clin Pharmacol; 2005 Aug; 45(8):969-73. PubMed ID: 16027409
[No Abstract] [Full Text] [Related]
12. Multiple-dose phase I study of transnasal butorphanol.
Shyu WC; Pittman KA; Robinson D; Barbhaiya RH
Clin Pharmacol Ther; 1993 Jul; 54(1):34-41. PubMed ID: 8330463
[TBL] [Abstract][Full Text] [Related]
13. Biopharmaceutical evaluation of transnasal, sublingual, and buccal disk dosage forms of butorphanol.
Shyu WC; Mayol RF; Pfeffer M; Pittman KA; Gammans RE; Barbhaiya RH
Biopharm Drug Dispos; 1993 Jul; 14(5):371-9. PubMed ID: 8218955
[TBL] [Abstract][Full Text] [Related]
14. The intravenous pharmacokinetics of butorphanol and detomidine dosed in combination compared with individual dose administrations to exercised horses.
Paine SW; Bright J; Scarth JP; Hincks PR; Pearce CM; Hannan C; Machnik M; Hillyer L
J Vet Pharmacol Ther; 2020 Mar; 43(2):162-170. PubMed ID: 32012314
[TBL] [Abstract][Full Text] [Related]
15. Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized, double-blind, placebo-controlled, parallel-group study.
Wermeling DP; Grant GM; Lee A; Alexander N; Rudy AC
Clin Ther; 2005 Apr; 27(4):430-40. PubMed ID: 15922816
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of intranasal butorphanol administered from a single-dose sprayer.
Davis GA; Rudy AIa; Archer SM; Wermeling DP
Am J Health Syst Pharm; 2005 Jan; 62(1):48-53. PubMed ID: 15658072
[TBL] [Abstract][Full Text] [Related]
17. Validation of a simplified method for determination of cimetidine in human plasma and urine by liquid chromatography with ultraviolet detection.
Iqbal T; Karyekar CS; Kinjo M; Ngan GC; Dowling TC
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jan; 799(2):337-41. PubMed ID: 14670753
[TBL] [Abstract][Full Text] [Related]
18. Disposition of the anti-ulcer medications ranitidine, cimetidine, and omeprazole following administration of multiple doses to exercised Thoroughbred horses.
Knych HK; Stanley SD; Arthur RM; McKemie DS
J Vet Pharmacol Ther; 2017 Jan; 40(1):92-96. PubMed ID: 27292271
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of dolasetron with coadministration of cimetidine or rifampin in healthy subjects.
Dimmitt DC; Cramer MB; Keung A; Arumugham T; Weir SJ
Cancer Chemother Pharmacol; 1999; 43(2):126-32. PubMed ID: 9923817
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of cimetidine in dogs after oral administration of cimetidine tablets.
Le Traon G; Burgaud S; Horspool LJ
J Vet Pharmacol Ther; 2009 Jun; 32(3):213-8. PubMed ID: 19646084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
